CN113423290A - Nicotine formulations comprising metal salts - Google Patents

Nicotine formulations comprising metal salts Download PDF

Info

Publication number
CN113423290A
CN113423290A CN201980076401.6A CN201980076401A CN113423290A CN 113423290 A CN113423290 A CN 113423290A CN 201980076401 A CN201980076401 A CN 201980076401A CN 113423290 A CN113423290 A CN 113423290A
Authority
CN
China
Prior art keywords
nicotine formulation
metal
aerosol
weight
nicotine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201980076401.6A
Other languages
Chinese (zh)
Other versions
CN113423290B (en
Inventor
I·陶里诺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philip Morris Products SA
Original Assignee
Philip Morris Products SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Products SA filed Critical Philip Morris Products SA
Publication of CN113423290A publication Critical patent/CN113423290A/en
Application granted granted Critical
Publication of CN113423290B publication Critical patent/CN113423290B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/165Chemical features of tobacco products or tobacco substitutes of tobacco substitutes comprising as heat source a carbon fuel or an oxidized or thermally degraded carbonaceous fuel, e.g. carbohydrates, cellulosic material
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/24Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241Extraction of specific substances
    • A24B15/243Nicotine
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10Devices using liquid inhalable precursors
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/20Devices using solid inhalable precursors
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/40Constructional details, e.g. connection of cartridges and battery parts
    • A24F40/48Fluid transfer means, e.g. pumps

Abstract

A nicotine formulation for use in an aerosol-generating system, the nicotine formulation comprising: one or more water-miscible polyols, wherein the water-miscible polyol content of the nicotine formulation is greater than or equal to about 5 wt%; and one or more metal salts, and wherein the one or more metal salts are selected from the group consisting of metal benzoates, metal cinnamates, metal cycloheptane carboxylates, metal levulinates, metal propionates, metal stearates, and metal undecanoates. An aerosol-generating article (500) for an aerosol-generating system (600), the aerosol-generating article (500) comprising the nicotine formulation (511). An aerosol-generating system (600) comprising a nicotine formulation (511) and a nebulizer (622) configured to generate an aerosol from the nicotine formulation (511).

Description

Nicotine formulations comprising metal salts
Technical Field
The present invention relates to a nicotine formulation for an aerosol-generating system. The invention also relates to an aerosol-generating article comprising a nicotine formulation for use in an aerosol-generating system and to an aerosol-generating system comprising a nicotine formulation and a nebulizer.
Background
Aerosol-generating systems for delivering nicotine to a user are known, the aerosol-generating systems comprising a nebulizer configured to generate an inhalable aerosol from a nicotine formulation. Some known aerosol-generating systems include a thermal atomizer (e.g., an electric heater) configured to heat and vaporize a nicotine formulation to produce an aerosol. Other known aerosol-generating systems include non-thermal atomizers configured to generate an aerosol from a nicotine formulation using, for example, impinging jet, ultrasonic, or vibrating mesh technology. A typical nicotine formulation for aerosol-generating systems is a liquid nicotine formulation comprising glycerol, propylene glycol and water as solvents.
It would be desirable to provide a nicotine formulation which, when used in an aerosol-generating system, exhibits more efficient nicotine evaporation and increased nicotine delivery to a user compared to typical liquid nicotine formulations.
It is also desirable to provide a nicotine formulation which shows a reduced risk of leakage when used in an aerosol-generating system compared to typical nicotine formulations.
According to the present invention there is provided a nicotine formulation for an aerosol-generating system, the nicotine formulation comprising: one or more water-miscible polyols; and one or more metal salts, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5% by weight.
Disclosure of Invention
According to the present invention there is also provided an aerosol-generating article for use in an aerosol-generating system, the aerosol-generating article comprising a nicotine formulation comprising: one or more water-miscible polyols; and one or more metal salts, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5% by weight.
According to the present invention there is also provided an aerosol-generating system comprising: a nicotine formulation comprising: one or more water-miscible polyols; and one or more metal salts, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5 wt%; and a nebulizer configured to generate an aerosol from the nicotine formulation.
According to the present invention there is also provided a nicotine formulation for use in an aerosol-generating system, the nicotine formulation comprising: one or more water-miscible polyols; and one or more metal salts, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5% by weight, and wherein the one or more metal salts are selected from the group consisting of metal benzoates, metal cinnamates, metal cycloheptane carboxylates, metal levulinates, metal propionates, metal stearates, and metal undecanoates.
According to the present invention there is also provided an aerosol-generating article for use in an aerosol-generating system, the aerosol-generating article comprising a nicotine formulation comprising: one or more water-miscible polyols; and one or more metal salts, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5% by weight, and wherein the one or more metal salts are selected from the group consisting of metal benzoates, metal cinnamates, metal cycloheptane carboxylates, metal levulinates, metal propionates, metal stearates, and metal undecanoates.
According to the present invention there is also provided an aerosol-generating system comprising: a nicotine formulation comprising: one or more water-miscible polyols; and one or more metal salts, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5 wt%, and a nebulizer configured to generate an aerosol from the nicotine formulation, and wherein the one or more metal salts are selected from the group consisting of metal benzoates, metal cinnamates, metal cycloheptane carboxylates, metal levulinates, metal propionates, metal stearates, and metal undecanoates.
As used herein with reference to the present invention, the term "nicotine" describes nicotine, nicotine base or nicotine salt. In embodiments where the nicotine formulation comprises a nicotine base or a nicotine salt, the amount of nicotine recited herein is the amount of free base nicotine or the amount of protonated nicotine, respectively.
As used herein with reference to the present invention, the term "water-miscible polyol" describes a polyol that is a liquid at 20 ℃ and is mixed with water in any proportion to form a homogeneous solution.
Unless otherwise indicated, the weight percentages of the nicotine formulation components described herein are based on the total weight of the nicotine formulation.
The linkage between the one or more metal salts and the one or more polyols in the nicotine formulation may increase the boiling point of the one or more polyols. This may advantageously enhance evaporation of nicotine from the nicotine formulation when used in an aerosol-generating system compared to a typical liquid nicotine formulation that does not comprise one or more metal salts.
Without wishing to be bound by theory, the interaction between the one or more metal salts in the nicotine formulation and the one or more polyol molecules may be stronger than the interaction between the one or more polyol molecules. This may result in more energy being required to vaporize the one or more polyols. In use, the inclusion of one or more metal salts in a nicotine formulation may thus advantageously increase the percentage of nicotine in an aerosol generated from the nicotine formulation by up to one order of magnitude compared to a typical liquid nicotine formulation that does not include one or more metal salts.
The bonding between the one or more metal salts and the one or more polyols in the nicotine formulation may increase the viscosity of the nicotine formulation compared to a typical liquid nicotine formulation that does not contain the one or more metal salts. This may advantageously reduce the risk of leakage of the nicotine formulation when used in an aerosol-generating system compared to a typical liquid nicotine formulation that does not comprise one or more metal salts.
Advantageously, the inclusion of propylene glycol in the nicotine formulation also shows improved evaporation of the nicotine formulation, which results in more aerosol being produced for a given heating cycle.
By including propylene glycol in the nicotine formulation, the nicotine content of the aerosol can also be improved due to evaporation of nicotine. It is believed that this may be due to the boiling point of propylene glycol (188 ℃) being lower than that of glycerol (290 ℃). However, if a significant amount of propylene glycol is present in the nicotine formulation, the nicotine content of the aerosol is found to be reduced. Thus, it may be advantageous to have a limited amount of propylene glycol in the nicotine formulation.
The nicotine formulation may be a liquid nicotine formulation.
As used herein with reference to the present invention, the term "liquid nicotine formulation" describes a liquid formulation comprising nicotine or a gel formulation comprising nicotine.
As used herein with reference to the present invention, the term "gel" describes a substantially dilute crosslinked system that does not exhibit flow when in a steady state.
The nicotine formulation can have a viscosity of greater than or equal to about 5 Pa-s at 25 ℃.
Preferably, the nicotine formulation has a viscosity of greater than or equal to about 10 pa-s at 25 ℃. For example, the nicotine formulation can have a viscosity of greater than or equal to about 25 pa-s, greater than or equal to about 50 pa-s, or greater than or equal to about 75 pa-s at 25 ℃.
More preferably, the nicotine formulation has a viscosity of greater than or equal to about 100 pa-s at 25 ℃. For example, the nicotine formulation can have a viscosity of greater than or equal to about 250 Pa-s, greater than or equal to about 500 Pa-s, or greater than or equal to about 750 Pa-s at 25 ℃.
Most preferably, the nicotine formulation has a viscosity of greater than or equal to about 1000 Pa-s at 25 ℃. For example, the nicotine formulation can have a viscosity of greater than or equal to about 2500 Pa-s, greater than or equal to about 5000 Pa-s, greater than or equal to about 7500 Pa-s, or greater than or equal to about 10,000 Pa-s at 25 ℃.
Unless otherwise stated, viscosity values described herein are 1 cubic centimeter (cm) using a parallel plate P20 probe with MP60(60mm diameter) measurement plate at 6 revolutions per minute (rpm) at 25 ℃ with a Thermo scientific HAAKE RheoStress 6000 rheometer, unless otherwise stated3) Viscosity obtained for a sample volume of nicotine formulation.
The nicotine formulation may be a solid nicotine formulation.
As used herein with reference to the present invention, the term "solid nicotine formulation" describes a solid formulation comprising nicotine.
Advantageously, the inclusion of propylene glycol in the nicotine formulation results in a solid formulation that is less rigid, less brittle, and more easily formed into a plug. These characteristics improve the subsequent processing and handling of the nicotine formulation during manufacture. The nicotine formulation according to the present invention may advantageously be used as an aerosol-forming substrate in an aerosol-generating system comprising an automatic or manual mechanism to move or advance the aerosol-forming substrate towards the atomizer, as shown in fig. 1 to 3. Thus, the aerosol-forming substrate remains in contact with the atomizer even if the aerosol-forming substrate is consumed during use. In such an aerosol-generating system, the propulsion mechanism may form a portion of the aerosol-generating article containing the nicotine formulation or a portion of the aerosol-generating article receiving an aerosol-generating device containing the nicotine formulation.
The nicotine formulation may comprise natural nicotine or synthetic nicotine.
The nicotine content of the nicotine formulation can be greater than or equal to about 0.5% by weight.
Preferably, the nicotine content of the nicotine formulation is greater than or equal to about 1% by weight. More preferably, the nicotine content of the nicotine formulation is greater than or equal to about 1.5% by weight.
The nicotine content of the nicotine formulation can be less than or equal to about 10 wt% or less than or equal to about 8 wt%.
Preferably, the nicotine content of the nicotine formulation is less than or equal to about 5% by weight. More preferably, the nicotine content of the nicotine formulation is less than or equal to about 3% by weight.
The nicotine content of the nicotine formulation may be between about 0.5% to about 10% by weight. For example, the nicotine content of the nicotine formulation may be between about 0.5% to about 8% by weight, between about 0.5% to about 5% by weight, or between about 0.5% to about 3% by weight.
Preferably, the nicotine content of the nicotine formulation is between about 1% to about 10% by weight. For example, the nicotine content of the nicotine formulation may be between about 1% to about 8% by weight, between about 1% to about 5% by weight, or between about 1% to about 3% by weight.
More preferably, the nicotine content of the nicotine formulation is between about 1.5% to about 10% by weight. For example, the nicotine content of the nicotine formulation may be between about 1.5% to about 8% by weight, between about 1.5% to about 5% by weight, or between about 1.5% to about 3% by weight.
The water-miscible polyol content of the nicotine formulation may be greater than or equal to about 5% by weight. The water-miscible polyol content of the nicotine formulation may be greater than or equal to about 10 wt.%, greater than or equal to about 20 wt.%, or greater than or equal to about 30 wt.%.
Preferably, the water-miscible polyol content of the nicotine formulation is greater than or equal to about 40% by weight. More preferably, the water-miscible polyol content of the nicotine formulation is greater than or equal to about 50% by weight. Most preferably, the water-miscible polyol content of the nicotine formulation is greater than or equal to about 60% by weight. For example, the water-miscible polyol content of the nicotine formulation may be greater than or equal to about 70 weight percent, greater than or equal to about 80 weight percent, or greater than or equal to about 90 weight percent.
Preferably, the water-miscible polyol content of the nicotine formulation is less than or equal to about 95% by weight.
The water-miscible polyol content of the nicotine formulation may be between about 5% to about 95% by weight. For example, the water-miscible polyol content of the nicotine formulation may be between about 10% to about 95% by weight, between about 20% to about 95% by weight, or between about 30% to about 95% by weight.
Preferably, the water-miscible polyol content of the nicotine formulation is between about 40% to about 95% by weight. More preferably, the water-miscible polyol content of the nicotine formulation is between about 50% to about 95% by weight. Most preferably, the water-miscible polyol content of the nicotine formulation is between about 60% to about 95% by weight. For example, the water-miscible polyol content of the nicotine formulation may be between about 70% to about 95% by weight, between about 80% to about 95% by weight, or between about 90% to about 95% by weight.
Preferably, the nicotine formulation comprises one or more water-miscible polyols selected from the group consisting of 1, 3-butanediol, glycerol, propylene glycol and triethylene glycol.
More preferably, the nicotine formulation comprises glycerol.
Most preferably, the nicotine formulation comprises vegetable glycerin.
Preferably, the glycerin content of the nicotine formulation is greater than or equal to about 5% by weight.
According to a preferred embodiment of the present invention there is provided a nicotine formulation for an aerosol-generating system, the nicotine formulation comprising: glycerol; and one or more metal salts, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5% by weight.
There is also provided in accordance with a preferred embodiment of the present invention an aerosol-generating article for use in an aerosol-generating system, the aerosol-generating article comprising a nicotine formulation comprising: glycerol; and one or more metal salts, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5% by weight.
There is also provided in accordance with a preferred embodiment of the present invention an aerosol-generating system comprising: a nicotine product comprising: glycerol; and one or more metal salts, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5 wt%; and a nebulizer configured to generate an aerosol from the nicotine formulation.
The glycerin content of the nicotine formulation can be greater than or equal to about 10 wt%, greater than or equal to about 20 wt%, or greater than or equal to about 30 wt%.
Preferably, the glycerin content of the nicotine formulation is greater than or equal to about 40% by weight. More preferably, the glycerol content of the nicotine formulation is greater than or equal to about 50% by weight. Most preferably, the glycerol content of the nicotine formulation is greater than or equal to about 60% by weight. For example, the glycerin content of the nicotine formulation can be greater than or equal to about 70 weight percent, greater than or equal to about 80 weight percent, or greater than or equal to about 90 weight percent.
Preferably, the glycerin content of the nicotine formulation is less than or equal to about 95% by weight.
The glycerin content of the nicotine formulation can be between about 5% to about 95% by weight. For example, the glycerin content of the nicotine formulation may be between about 10 wt% to about 95 wt%, between about 20 wt% to about 95 wt%, or between about 30 wt% to about 95 wt%.
Preferably, the glycerin content of the nicotine formulation is between about 40% to about 95% by weight. More preferably, the glycerin content of the nicotine formulation is between about 50% to about 95% by weight. Most preferably, the glycerol content of the nicotine formulation is between about 60% to about 95% by weight. For example, the glycerin content of the nicotine formulation may be between about 70% to about 95% by weight, between about 80% to about 95% by weight, or between about 90% to about 95% by weight.
The nicotine formulation may comprise glycerin and propylene glycol.
In embodiments wherein the nicotine formulation comprises glycerin and propylene glycol, preferably the ratio of the glycerin weight percent content to the propylene glycol weight percent content of the nicotine formulation is greater than or equal to about 1. More preferably, the nicotine formulation has a ratio of glycerin weight percent content to propylene glycol weight percent content of greater than or equal to about 1.5. For example, the ratio of the weight percent content of glycerin to the weight percent content of propylene glycol of the nicotine formulation can be greater than or equal to about 2, greater than or equal to about 2.5, or greater than or equal to about 3.
The metal salt content of the nicotine formulation can be greater than or equal to about 0.75 wt% or greater than or equal to about 1 wt%.
Preferably, the metal salt content of the nicotine formulation is less than or equal to about 15% by weight. More preferably, the metal salt content of the nicotine formulation is less than or equal to about 12% by weight. For example, the metal salt content of the nicotine formulation can be less than or equal to about 10% by weight.
Preferably, the metal salt content of the nicotine formulation is between about 0.5% to about 15% by weight. For example, the metal salt content of the nicotine formulation may be between about 0.5 wt% to about 12 wt% or between about 0.5 wt% to about 10 wt%.
The metal salt content of the nicotine formulation may be between about 0.75% to about 15% by weight. For example, the metal salt content of the nicotine formulation may be between about 0.75 wt% to about 12 wt% or between about 0.75 wt% to about 10 wt%.
The metal salt content of the nicotine formulation may be between about 1% to about 15% by weight. For example, the metal salt content of the nicotine formulation may be between about 1% to about 12% by weight or between about 1% to about 10% by weight.
The molar mass of the one or more metal salts can be less than or equal to about 500g/mol or less than or equal to about 400 g/mol.
Preferably, the one or more metal salts are selected from the group consisting of metal alginates, metal benzoates, metal cinnamates, metal cycloheptane carboxylates, metal levulinates, metal propionates, metal stearates, and metal undecanoates.
Preferably, the one or more metal salts are selected from the group consisting of metal benzoates, metal cinnamates, metal cycloheptane carboxylates, metal levulinates, metal propionates, metal stearates and metal undecanoates.
Preferably, the one or more metal salts are selected from the group consisting of metal cinnamates, metal cycloheptane carboxylates, metal levulinates, metal propionates, metal stearates, and metal undecanoates.
Preferably wherein the one or more metal salts are selected from the group consisting of metal cinnamates, metal cycloheptane carboxylates, metal stearates, and metal undecanoates.
According to a preferred embodiment of the present invention there is provided a nicotine formulation for an aerosol-generating system, the nicotine formulation comprising: one or more water-miscible polyols; and one or more metal salts selected from the group consisting of metal alginates, metal benzoates, metal cinnamates, metal cycloheptane carboxylates, metal levulinates, metal propionates, metal stearates, and metal undecanoates, wherein the metal salt content of the nicotine formulation is greater than or equal to 0.5% by weight.
There is also provided in accordance with a preferred embodiment of the present invention an aerosol-generating article for use in an aerosol-generating system, the aerosol-generating article comprising a nicotine formulation comprising: one or more water-miscible polyols; and one or more metal salts selected from the group consisting of metal alginates, metal benzoates, metal cinnamates, metal cycloheptane carboxylates, metal levulinates, metal propionates, metal stearates, and metal undecanoates, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5% by weight.
There is also provided in accordance with a preferred embodiment of the present invention an aerosol-generating system comprising: a nicotine formulation comprising: one or more water-miscible polyols; and one or more metal salts selected from the group consisting of metal alginates, metal benzoates, metal cinnamates, metal cycloheptane carboxylates, metal levulinates, metal propionates, metal stearates, and metal undecanoates, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5% by weight; and a nebulizer configured to generate an aerosol from the nicotine formulation.
More preferably, the one or more metal salts are selected from the group consisting of metal alginates and metal stearates.
According to a preferred embodiment of the present invention there is provided a nicotine formulation for an aerosol-generating system, the nicotine formulation comprising: one or more water-miscible polyols; and one or more metal salts selected from the group consisting of metal alginates and metal stearates, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5% by weight.
There is also provided in accordance with a preferred embodiment of the present invention an aerosol-generating article for use in an aerosol-generating system, the aerosol-generating article comprising a nicotine formulation comprising: one or more water-miscible polyols; and one or more metal salts selected from the group consisting of metal alginates and metal stearates, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5% by weight.
There is also provided in accordance with a preferred embodiment of the present invention an aerosol-generating system comprising: a nicotine formulation comprising: one or more water-miscible polyols; and one or more metal salts selected from the group consisting of metal alginates and metal stearates, wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5 weight percent; and a nebulizer configured to generate an aerosol from the nicotine formulation.
Particularly preferably, the nicotine formulation comprises one or more metal stearates.
Advantageously, the covalent bonding between the one or more metal stearates and the one or more water miscible polyols in the nicotine formulation can further increase the boiling point of the one or more water miscible polyols. When the formulation comprises nicotine, this may advantageously enhance the evaporation efficiency of nicotine when used in an aerosol-generating system compared to a typical liquid nicotine formulation not comprising one or more metal stearates.
Preferably, the nicotine formulation comprises glycerol and one or more metal salts selected from the group consisting of metal alginate and metal stearate.
Particularly preferably, the nicotine formulation comprises glycerol and one or more metal stearates.
The covalent bonding between the one or more metal stearates and the glycerin in the nicotine formulation can increase the boiling point of the glycerin. This may advantageously enhance evaporation of nicotine from the nicotine formulation when used in an aerosol-generating system.
The covalent bonding between the one or more metal stearates and the glycerin in the nicotine formulation can increase the viscosity of the nicotine formulation. This may advantageously reduce the risk of leakage of the nicotine formulation when used in an aerosol-generating system.
The nicotine formulation may comprise one or more of any suitable metal salts.
Preferably, the one or more metal salts are one or more alkali metal salts.
More preferably, the one or more metal salts are one or more sodium salts.
More preferably, the one or more metal salts are one or more sodium salts selected from the group consisting of sodium alginate, sodium benzoate, sodium cinnamate, sodium cycloheptanoate, sodium levulinate, sodium propionate, sodium stearate, and sodium undecanoate.
Most preferably, the one or more salts are one or more sodium salts selected from the group consisting of sodium alginate and sodium stearate.
According to a preferred embodiment of the present invention there is provided a nicotine formulation for an aerosol-generating system, the nicotine formulation comprising: one or more water-miscible polyols; and one or more sodium salts selected from the group consisting of sodium alginate and sodium stearate, wherein the sodium salt content of the nicotine formulation is greater than or equal to about 0.5% by weight.
There is also provided in accordance with a preferred embodiment of the present invention an aerosol-generating article for use in an aerosol-generating system, the aerosol-generating article comprising a nicotine formulation comprising: one or more water-miscible polyols; and one or more sodium salts selected from the group consisting of sodium alginate and sodium stearate, wherein the sodium salt content of the nicotine formulation is greater than or equal to about 0.5% by weight.
There is also provided in accordance with a preferred embodiment of the present invention an aerosol-generating system comprising: a nicotine formulation comprising: one or more water-miscible polyols; and one or more sodium salts selected from the group consisting of sodium alginate and sodium stearate, wherein the sodium salt content of the nicotine formulation is greater than or equal to about 0.5% by weight; and a nebulizer configured to generate an aerosol from the nicotine formulation.
In embodiments wherein the nicotine formulation comprises sodium alginate, the sodium alginate content of the nicotine formulation may be greater than or equal to about 0.25% by weight or greater than or equal to about 0.5% by weight. For example, the sodium alginate content of the nicotine formulation may be greater than or equal to about 0.75% by weight or greater than or equal to about 1% by weight.
Preferably, the sodium alginate content of the nicotine formulation is less than or equal to about 15% by weight. More preferably, the sodium alginate content of the nicotine formulation is less than or equal to about 12% by weight. For example, the sodium alginate content of the nicotine formulation can be less than or equal to about 10% by weight.
In embodiments wherein the nicotine formulation comprises sodium alginate, the sodium alginate content of the nicotine formulation may be between about 0.25% to about 15% by weight. For example, the sodium alginate content of the nicotine formulation may be between about 0.25% to about 12% by weight or between about 0.25% to about 10% by weight.
In embodiments wherein the nicotine formulation comprises sodium alginate, the sodium alginate content of the nicotine formulation may be between about 0.5% to about 15% by weight. For example, the sodium alginate content of the nicotine formulation may be between about 0.5% to about 12% by weight or between about 0.5% to about 10% by weight.
The sodium alginate of the nicotine formulation may be between about 0.75% to about 15% by weight. For example, the sodium alginate of the nicotine formulation may be between about 0.75% to about 12% by weight or between about 0.75% to about 10% by weight.
The sodium alginate of the nicotine formulation may be between about 1% to about 15% by weight. For example, the sodium alginate content of the nicotine formulation may be between about 1% to about 12% by weight or between about 1% to about 10% by weight.
Particularly preferably, the nicotine formulation comprises sodium stearate.
Metal salts with high weight average molecular weight may improve the above-mentioned advantages related to nicotine evaporation efficiency. However, if the weight average molecular weight of the metal salt is too high, characteristics such as solubility begin to be negatively affected. Advantageously, the inclusion of sodium stearate in the formulation may provide the best compromise in terms of increasing the evaporation efficiency of nicotine while maintaining solubility.
In embodiments wherein the nicotine formulation comprises sodium stearate, it is preferred that the sodium stearate content of the nicotine formulation is greater than or equal to about 0.25% by weight. More preferably, the nicotine formulation has a sodium stearate content of greater than or equal to about 0.5% by weight.
According to a preferred embodiment of the present invention there is provided a nicotine formulation for an aerosol-generating system, the nicotine formulation comprising: one or more water-miscible polyols; and sodium stearate, wherein the nicotine formulation has a sodium stearate content of greater than or equal to about 0.5% by weight.
There is also provided in accordance with a preferred embodiment of the present invention an aerosol-generating article for use in an aerosol-generating system, the aerosol-generating article comprising a nicotine formulation comprising: one or more water-miscible polyols; and sodium stearate, wherein the nicotine formulation has a sodium stearate content of greater than or equal to about 0.5% by weight.
There is also provided in accordance with a preferred embodiment of the present invention an aerosol-generating system comprising: a nicotine formulation comprising: one or more water-miscible polyols; and sodium stearate, wherein the nicotine formulation has a sodium stearate content of greater than or equal to about 0.5% by weight; and a nebulizer configured to generate an aerosol from the nicotine formulation.
For example, the sodium stearate content of the nicotine formulation can be greater than or equal to about 0.75% by weight or greater than or equal to about 1% by weight.
Preferably, the nicotine formulation has a sodium stearate content of less than or equal to about 15% by weight. More preferably, the nicotine formulation has a sodium stearate content of less than or equal to about 12% by weight. For example, the nicotine formulation can have a sodium stearate content of less than or equal to about 10% by weight.
Preferably, the nicotine formulation has a sodium stearate content of between about 0.25% to about 15% by weight. For example, the sodium stearate content of the nicotine formulation may be between about 0.25% to about 12% by weight or between about 0.25% to about 10% by weight.
More preferably, the sodium stearate content of the nicotine formulation is between about 0.5% to about 15% by weight. For example, the sodium stearate content of the nicotine formulation may be between about 0.5% to about 12% by weight or between about 0.5% to about 10% by weight.
The nicotine formulation has a sodium stearate content between about 0.75% to about 15% by weight. For example, the sodium stearate content of the nicotine formulation is between about 0.75% to about 12% by weight or between about 0.75% to about 10% by weight.
The sodium stearate content of the nicotine formulation may be between about 1% to about 15% by weight. For example, the sodium stearate content of the nicotine formulation may be between about 1% to about 12% by weight or between about 1% to about 10% by weight.
Particularly preferably, the nicotine formulation comprises glycerol and sodium stearate.
Covalent bonding between sodium stearate and glycerol in nicotine formulations can increase the boiling point of glycerol. This may advantageously enhance evaporation of nicotine from the nicotine formulation when used in an aerosol-generating system.
Covalent bonding between sodium stearate and glycerol in a nicotine formulation can increase the viscosity of the nicotine formulation. This may advantageously reduce the risk of leakage of the nicotine formulation when used in an aerosol-generating system.
According to a particularly preferred embodiment of the present invention there is provided a nicotine formulation for an aerosol-generating system, the nicotine formulation comprising: glycerol; and sodium stearate, wherein the nicotine formulation has a sodium stearate content of greater than or equal to about 0.5% by weight.
There is also provided in accordance with a particularly preferred embodiment of the present invention an aerosol-generating article for use in an aerosol-generating system, the aerosol-generating article comprising a nicotine formulation comprising: glycerol; and sodium stearate, wherein the nicotine formulation has a sodium stearate content of greater than or equal to about 0.5 times by weight.
There is also provided in accordance with a preferred embodiment of the present invention an aerosol-generating system comprising: a nicotine formulation comprising: glycerol; and sodium stearate, wherein the nicotine formulation has a sodium stearate content of greater than or equal to about 0.5% by weight; and a nebulizer configured to generate an aerosol from the nicotine formulation.
The nicotine formulation may comprise water.
The water content of the nicotine formulation can be less than or equal to about 20 wt% or less than or equal to about 15 wt%.
Preferably, the water content of the nicotine formulation is less than or equal to about 10% by weight. For example, the water content of the nicotine formulation can be less than or equal to about 8% by weight or less than or equal to about 6% by weight.
In embodiments where the nicotine formulation comprises water, the water content of the nicotine formulation can be greater than or equal to about 1% by weight. For example, the water content of the nicotine formulation can be greater than or equal to about 2 wt% or greater than or equal to about 3 wt%.
The water content of the nicotine formulation may be between about 1% to about 20% by weight. For example, the water content of the nicotine formulation may be between about 2% to about 20% by weight or between about 3% to about 20% by weight.
The water content of the nicotine formulation may be between about 1% to about 15% by weight. For example, the water content of the nicotine formulation may be between about 2% to about 15% by weight or between about 3% to about 15% by weight.
In embodiments where the nicotine formulation comprises water, preferably the water content of the nicotine formulation is between about 1% to about 10% by weight. For example, the water content of the nicotine formulation may be between about 2% to about 10% by weight or between about 3% to about 10% by weight.
The water content of the nicotine formulation may be between about 1% to about 8% by weight. For example, the water content of the nicotine formulation may be between about 2% to about 8% by weight or between about 3% to about 8% by weight.
The water content of the nicotine formulation may be between about 1% to about 6% by weight. For example, the water content of the nicotine formulation may be between about 2% to about 6% by weight or between about 3% to about 6% by weight.
The nicotine formulation may comprise one or more organic acids.
In some embodiments, the one or more organic acids may be water soluble organic acids. As used herein with reference to the present invention, the term "water-soluble organic acid" describes an organic acid having a water solubility at 20 ℃ of greater than or equal to about 100mg/ml, preferably greater than or equal to about 500mg/ml, more preferably greater than or equal to about 750mg/ml, and most preferably greater than or equal to about 1000 mg/ml.
Unless otherwise indicated, the water solubility values described herein are water solubilities measured based on the following preliminary tests: OECD (1995), Test No.105 (run No. 105): Water Solubility, OECD Guidelines for the Testing of Chemicals (the Guidelines for OECD Chemicals Testing), section 1, Paris OECD Press, https:// doi.org/10.1787/9789264069589-en. In a stepwise procedure, increasing volumes of distilled water were added to 0.1g of sample (solid matter must be crushed) in a 10ml glass plug cylinder at 20 ℃. However, when the substance is an acid, the sample is added to distilled water in a first step. After each addition of a certain amount of water, the mixture was shaken for 10 minutes and visually inspected for undissolved parts in the sample. If the sample or part thereof has not dissolved after the addition of 10ml of water, the experiment is continued in a 100ml graduated cylinder. Table 1 below gives the approximate solubility in the volume of water in which the sample was completely dissolved.
When the solubility is low, it may take a long time to dissolve the substance, at least 24 hours should be allowed. If after 24 hours the material has not dissolved, the cylinder is placed in the ultrasonic bath at 40 ℃ for 15 minutes and allowed to stand for a further 24 hours (up to 96 hours). If the substance is not yet dissolved, the solubility is considered to be below the limit or insoluble.
Figure BDA0003074903050000131
TABLE 1
The nicotine formulation may comprise one or more carboxylic acids.
Suitable carboxylic acids include, but are not limited to, acetic acid, citric acid, lactic acid, malic acid, malonic acid, and pyruvic acid.
In embodiments wherein the nicotine formulation comprises one or more organic acids, the organic acid content of the nicotine formulation can be greater than or equal to about 0.5 wt% or greater than or equal to about 1 wt%.
Preferably, the organic acid content of the nicotine formulation is less than or equal to about 6% by weight. More preferably, the organic acid content of the nicotine formulation is less than or equal to about 4% by weight. For example, the organic acid content of the nicotine formulation can be less than or equal to about 2% by weight.
In embodiments where the nicotine formulation comprises one or more organic acids, the organic acid content of the nicotine formulation can be between about 0.5% to about 6% by weight. For example, the organic acid content of the nicotine formulation may be between about 0.5% to about 4% by weight or between about 0.5% to about 2% by weight.
The organic acid content of the nicotine formulation may be between about 1% to about 6% by weight. For example, the organic acid content of the nicotine formulation may be between about 1% to about 4% by weight or between about 1% to about 2% by weight.
The nicotine formulation may comprise one or more flavors. Suitable flavorants include, but are not limited to, menthol.
Preferably, the flavor content of the nicotine formulation is less than or equal to about 4% by weight. More preferably, the flavor content of the nicotine formulation is less than or equal to about 3% by weight.
According to the present invention there is also provided an aerosol-generating article for use in an aerosol-generating system, the aerosol-generating article comprising a nicotine formulation according to the present invention.
The aerosol-generating article may comprise a nebulizer configured to generate an aerosol from a nicotine formulation.
The aerosol-generating article may comprise a cartridge.
The cartridge containing the nicotine formulation and the nebulizer may be referred to as a "cartomiser" (cartomiser).
The atomiser may be a thermal atomiser.
As used herein with reference to the present invention, the term "thermal atomizer" describes an atomizer configured to heat a nicotine formulation to generate an aerosol.
The aerosol-generating article may comprise any suitable type of thermal atomiser.
The thermal atomizer may comprise an electric heater. For example, the thermal atomizer may comprise an electric heater comprising a resistive heating element or an inductive heating element.
The heating element may be a mesh or net element or layer. In such embodiments, the nicotine formulation may flow into the interstitial spaces forming the mesh or mesh element.
The atomizer may be a non-thermal atomizer.
As used herein with reference to the present invention, the term "non-thermal nebulizer" describes a nebulizer configured to generate an aerosol from a nicotine article by a method other than heating.
The aerosol-generating article may comprise any suitable type of non-thermal atomiser.
For example, the non-thermal atomizer may be an impinging jet atomizer, an ultrasonic atomizer, or a vibrating mesh atomizer.
According to the present invention, there is also provided an aerosol-generating system comprising a nicotine formulation according to the present invention and a nebulizer configured to generate an aerosol from the nicotine formulation.
The atomiser may be a thermal atomiser.
The aerosol-generating system may comprise any suitable type of thermal atomiser.
The thermal atomizer may comprise an electric heater. For example, the thermal atomizer may comprise an electric heater comprising a resistive heating element or an inductive heating element.
The heating element may be a mesh or net element or layer. In such embodiments, the nicotine formulation may flow into the interstitial spaces forming the mesh or mesh element.
The atomizer may be a non-thermal atomizer.
The aerosol-generating system may comprise any suitable type of non-thermal atomiser.
For example, the non-thermal atomizer may be an impinging jet atomizer, an ultrasonic atomizer, or a vibrating mesh atomizer.
An aerosol-generating system may comprise an aerosol-generating article comprising a nicotine formulation according to the invention and an aerosol-generating device comprising a housing defining a device cavity configured to receive at least a portion of the aerosol-generating article.
An aerosol-generating system may comprise a consumable aerosol-generating article comprising a nicotine formulation according to the invention and a reusable aerosol-generating device comprising a housing defining a device cavity configured to receive at least a portion of the aerosol-generating article.
The aerosol-generating device may comprise a battery and control electronics.
The aerosol-generating system may comprise: an aerosol-generating article comprising a nicotine formulation and a nebulizer according to the invention; and an aerosol-generating device comprising a housing defining a device cavity configured to receive at least a portion of an aerosol-generating article.
The aerosol-generating system may comprise: an aerosol-generating article comprising a nicotine formulation according to the invention; and an aerosol-generating device comprising a housing defining a device cavity configured to receive at least a portion of an aerosol-generating article; and an atomizer.
For the avoidance of doubt, features described above in relation to one aspect of the invention may also be applicable to other aspects of the invention. In particular, the features described above in relation to the nicotine formulation of the invention may also relate, where appropriate, to the aerosol-generating article and the aerosol-generating system of the invention. Similarly, features described above in relation to the aerosol article of the invention may also relate, where appropriate, to the aerosol-generating system of the invention, and vice versa.
Drawings
Embodiments of the invention will now be described, by way of example only, with reference to the following examples and the accompanying drawings, in which:
figure 1 is a schematic cross-sectional side view of an aerosol-generating system comprising an aerosol-generating device and an aerosol-generating article comprising a nicotine-containing formulation according to the invention;
figure 2 is a schematic cross-sectional view of a spring-loaded aerosol-generating article comprising a nicotine formulation according to the invention; and is
Figure 3 is a schematic cross-sectional view of a "lipstick" push mechanism aerosol-generating article comprising a nicotine formulation according to the present invention.
Detailed Description
Fig. 1 shows an aerosol-generating system 400 comprising an aerosol-generating device 600 and an aerosol-generating article 500.
The aerosol-generating device 600 shown in fig. 1 is configured to receive an aerosol-generating article 500. The aerosol-generating device 600 comprises a housing 601 and a container 610 formed in the housing 601. The container 610 is configured to receive the aerosol-generating article 500. The container 610 may be sized and shaped such that at least a portion of the aerosol-generating article 500 remains outside of the container 610 when the aerosol-generating article 500 is inserted into the container 610.
The aerosol-generating device 600 comprises a heating element 622 at the closed end 610 of the container. The heating element 622 comprises a mesh layer.
The aerosol-generating device 600 may include a power supply 651 operably connected to a controller 653 and an optional graphical user interface 652. A power source 651 operatively connected to the controller 653 may be disposed within the housing 601. A graphical user interface 652 may be provided on the housing 601.
The aerosol-generating article 500 comprises a body 512 defining a cavity 512 having a cavity opening 515. An aerosol-forming substrate 511 is disposed in the cavity 510. The body 512 includes a closed end portion 551 which may be a ring or rotating portion or a stationary support.
Alternatively, the aerosol-generating article 500 may comprise a propulsion mechanism, which may be arranged at the proximal end of the aerosol-generating article 500. The propulsion mechanism may be configured as a piston-type element. The propulsion mechanism may be configured as a screw-type element. The propulsion mechanism may convert rotational movement into lateral movement.
When the aerosol-generating article 500 is received into the container 610 of the aerosol-generating device 600, the cavity opening of the aerosol-generating article 500 abuts the heating element 622. The heating element 622 is disposed near the cavity opening 515. The aerosol-forming substrate 511 of the aerosol-generating article 500 is a nicotine formulation according to the invention that can flow into and through the web of heating elements 622.
Air may flow into the container 610 of the aerosol-generating device 600 and entrain volatile aerosol components from the heated aerosol-forming substrate 511 and pass through the aerosol-generating device 600 via the air passage 650 to the consumer.
Figure 2 is a schematic cross-sectional view of a spring-loaded aerosol-generating article 500. The aerosol-generating article 500 comprises a body 512 defining a cavity 510 having a cavity opening 515. An aerosol-forming substrate 511 is disposed in the cavity 512. The heating element 622 is disposed near the cavity opening 515. The body 512 includes a closed end portion 551, which may be a fixed support. The spring element 517 biases the movable rigid base 513 against a spring support 551 fixed to the body 512. The aerosol-forming substrate 511 is a nicotine formulation according to the invention.
Figure 3 is a schematic cross-sectional view of a "lipstick" advancing mechanism aerosol-generating article 500. The aerosol-generating article 500 comprises a body 512 defining a cavity 510 having a cavity opening 515. An aerosol-forming substrate 511 is disposed in the cavity 512. The heating element 622 is disposed near the cavity opening 515. The body 512 contains a ring or rotating element 551 that is connected to a movable rigid base 513 and converts rotational motion to lateral motion via a spiral or helical groove 514. Pins (not shown) connect the rigid base 513 to the spiral or helical groove 514 to provide lateral movement of the aerosol-forming substrate 511. The aerosol-forming substrate 511 is a nicotine formulation according to the invention.
In an alternative embodiment (not shown), the aerosol-generating system may comprise an automated mechanism to move or advance the aerosol-forming substrate 511 towards the heating element 622. In such an alternative embodiment, the controller 653 of the aerosol-generating device 600 may activate an actuator or advancing mechanism on either the aerosol-generating article 500 or the aerosol-generating device 600 to advance the aerosol-forming substrate 511 and the rigid base 513 towards the heating element 622 upon detecting that the heating element 622 is not in contact with the aerosol-forming substrate 511.
Examples
Three liquid nicotine formulations according to the invention (examples A, B and C) were prepared having the compositions and viscosities shown in table 2.
Figure BDA0003074903050000171
TABLE 2
Three solid nicotine formulations according to the invention (examples D, E and F) were prepared having the compositions shown in table 3.
Figure BDA0003074903050000181
TABLE 3
Each of the nicotine compositions is prepared by:
(1) heating one or more polyols to a temperature of about 100 ℃ to about 120 ℃ using a heated plate agitator;
(2) adding a fine powder of one or more metal salts to one or more polyols while continuing to stir, and then continuing to heat the mixture to a temperature of about 85 ℃ to about 95 ℃ until the mixture is clear;
(3) adding water to the clarified mixture;
(4) reducing the heating temperature of the mixture to about 50 ℃ and adding nicotine to the mixture while continuing to stir; and
(5) the heated mixture is poured into a mold, and then the mixture is allowed to cool and condense to form the nicotine composition.
As shown in table 2, inclusion of less than or equal to about 1 wt% metal salt (sodium stearate) results in a liquid nicotine formulation having a viscosity of greater than or equal to about 185Pa s at 25 ℃.
As shown in table 3, inclusion of greater than or equal to about 8% by weight of metal salts (sodium stearate and sodium alginate) results in a solid nicotine formulation.

Claims (15)

1. A nicotine formulation for use in an aerosol-generating system, the nicotine formulation comprising:
one or more water-miscible polyols; and
one or more metal salts of a metal selected from the group consisting of,
wherein the metal salt content of the nicotine formulation is greater than or equal to about 0.5% by weight, and
wherein the one or more metal salts are selected from the group consisting of metal benzoates, metal cinnamates, metal cycloheptane carboxylates, metal levulinates, metal propionates, metal stearates, and metal undecanoates.
2. A nicotine formulation according to claim 1, having a metal salt content of less than or equal to about 15% by weight.
3. A nicotine formulation according to claim 1 or 2, wherein the one or more metal salts are selected from the group consisting of metal cinnamates, metal cycloheptane carboxylates, metal levulinates, metal propionates, metal stearates and metal undecanoates, preferably wherein the one or more metal salts are selected from the group consisting of metal cinnamates, metal cycloheptane carboxylates, metal stearates and metal undecanoates.
4. A nicotine formulation according to any one of claims 1 to 3, wherein the one or more metal salts comprise sodium stearate.
5. A nicotine formulation according to any of claims 1 to 4, comprising sodium stearate, wherein the sodium stearate content of the nicotine formulation is greater than or equal to about 0.25 wt%.
6. A nicotine formulation according to any one of claims 1 to 5 having a water miscible polyol content of at least about 40% by weight.
7. A nicotine formulation according to any one of claims 1 to 6, wherein the one or more water miscible polyols comprises glycerol.
8. A nicotine formulation according to claim 7, wherein the one or more water-miscible polyols comprise glycerol and propylene glycol.
9. A nicotine formulation according to claim 8, wherein the ratio of the weight percent content of glycerin to the weight percent content of propylene glycol of the nicotine formulation is greater than or equal to about 1.
10. A nicotine formulation according to any one of claims 1 to 9, comprising water.
11. A nicotine formulation according to claim 10 having a water content of less than or equal to about 10% by weight.
12. A nicotine formulation according to any one of claims 1 to 11, comprising one or more organic acids, wherein the organic acid content of the nicotine formulation is between about 0.5% to about 4% by weight.
13. A nicotine formulation according to any one of claims 1 to 13, wherein the viscosity of the nicotine formulation is greater than or equal to about 10 Pa-s at 25 ℃.
14. An aerosol-generating article for use in an aerosol-generating system, the aerosol-generating article comprising a nicotine formulation according to any one of claims 1 to 13.
15. An aerosol-generating system, comprising:
a nicotine formulation according to any one of claims 1 to 13; and
a nebulizer configured to generate an aerosol from the nicotine formulation.
CN201980076401.6A 2018-12-28 2019-12-18 Nicotine formulation comprising a metal salt Active CN113423290B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18248224 2018-12-28
EP18248224.0 2018-12-28
PCT/EP2019/086110 WO2020136062A1 (en) 2018-12-28 2019-12-18 Nicotine formulation comprising metal salt

Publications (2)

Publication Number Publication Date
CN113423290A true CN113423290A (en) 2021-09-21
CN113423290B CN113423290B (en) 2023-08-04

Family

ID=65010480

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980076401.6A Active CN113423290B (en) 2018-12-28 2019-12-18 Nicotine formulation comprising a metal salt

Country Status (7)

Country Link
US (1) US20220071268A1 (en)
EP (1) EP3902416B1 (en)
JP (1) JP2022516404A (en)
KR (1) KR20210107690A (en)
CN (1) CN113423290B (en)
BR (1) BR112021009438A2 (en)
WO (1) WO2020136062A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101090713A (en) * 2004-11-30 2007-12-19 费尔廷制药公司 Method of providing fast relief to a user of a nicotine chewing gum
CN105530825A (en) * 2013-07-19 2016-04-27 奥驰亚客户服务有限责任公司 Liquid aerosol formulation of an electronic smoking article
CN106714589A (en) * 2014-04-30 2017-05-24 奥驰亚客户服务有限责任公司 Liquid aerosol formulation of an electronic smoking article
US20180199617A1 (en) * 2017-01-18 2018-07-19 Bianca Iodice Tobacco Free Hookah Smoking Gel
US20180256560A1 (en) * 2015-09-22 2018-09-13 Ttp Plc Liquid nicotine formulation
CN109007958A (en) * 2018-09-13 2018-12-18 云南中烟工业有限责任公司 A kind of tobacco roasting Studies of The Aromatic Substances and the preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5105836A (en) * 1989-09-29 1992-04-21 R. J. Reynolds Tobacco Company Cigarette and smokable filler material therefor
US5484604A (en) * 1990-07-21 1996-01-16 Chatfield Pharmaceuticals Limited Cross-linked alginate transdermal medicine delivery devices
US7647932B2 (en) * 2005-08-01 2010-01-19 R.J. Reynolds Tobacco Company Smoking article
SE530184C2 (en) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesive pharmaceutical film composition containing low viscous alginates
US10092715B2 (en) * 2006-09-27 2018-10-09 Niconovum Usa, Inc. Directional use
WO2013143891A1 (en) * 2012-03-27 2013-10-03 Uppsalagruppen Medical Ab Nicotine formulation
KR20180086196A (en) * 2015-10-23 2018-07-30 넥스트 제너레이션 랩스, 엘엘씨 Nicotine composition for baffling apparatus and baffling apparatus using same

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101090713A (en) * 2004-11-30 2007-12-19 费尔廷制药公司 Method of providing fast relief to a user of a nicotine chewing gum
CN105530825A (en) * 2013-07-19 2016-04-27 奥驰亚客户服务有限责任公司 Liquid aerosol formulation of an electronic smoking article
CN106714589A (en) * 2014-04-30 2017-05-24 奥驰亚客户服务有限责任公司 Liquid aerosol formulation of an electronic smoking article
US20180256560A1 (en) * 2015-09-22 2018-09-13 Ttp Plc Liquid nicotine formulation
US20180199617A1 (en) * 2017-01-18 2018-07-19 Bianca Iodice Tobacco Free Hookah Smoking Gel
CN109007958A (en) * 2018-09-13 2018-12-18 云南中烟工业有限责任公司 A kind of tobacco roasting Studies of The Aromatic Substances and the preparation method and application thereof

Also Published As

Publication number Publication date
CN113423290B (en) 2023-08-04
US20220071268A1 (en) 2022-03-10
WO2020136062A1 (en) 2020-07-02
JP2022516404A (en) 2022-02-28
EP3902416B1 (en) 2023-02-08
KR20210107690A (en) 2021-09-01
BR112021009438A2 (en) 2021-08-17
EP3902416A1 (en) 2021-11-03

Similar Documents

Publication Publication Date Title
CN113163848B (en) Low viscosity liquid nicotine formulations
EP3703655B1 (en) Aerosolisable gel
CN113163844B (en) High viscosity nicotine formulations
CN113423290B (en) Nicotine formulation comprising a metal salt
US20230023830A1 (en) A formulation for use in an aerosol-generating system
CN113164610A (en) Liquid nicotine formulation comprising a low molar mass metal salt
RU2812319C2 (en) Nicotine composition containing metal salt
RU2804837C2 (en) High-viscosity nicotine composition
CN114945287A (en) Formulations for aerosol-generating systems
RU2814483C1 (en) Composition for use in aerosol generating system

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant